XEDEN VET 150 MG TABLET FOR DOGS
XEDEN VET 150 MG TABLET FOR DOGS
Authorised
- Enrofloxacin
Product identification
Medicine name:
XEDEN VET 150 MG TABLET FOR DOGS
Xeden 150 mg Tablet
Xeden 150 mg Comprimé
Xeden 150 mg Tablette
Active substance:
- Enrofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin150.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Cardboard box with 20 blisters of 6 tablets
- Cardboard box with 2 blisters of 6 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V320607
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0186/003
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: